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Introduction and objectives: Different percutaneous interventional procedures are needed to reach and maintain
adequate anatomical and physiological conditions for the Fontan circulation. We aim to describe the experience
gained at a children's hospital in such interventions, and to analyze the clinical outcomes.
Methods: Retrospective study of all patients with Fontan circulation completed between 1995 and 2013. We an-
alyzed the clinical characteristics and the different types of percutaneous interventions performed, considering
three different periods of time: before Glenn surgery, between Glenn and Fontan surgeries, and after Fontan
was completed. Survival and time to indication of percutaneous interventions in each period were analyzed, as
well as the clinical situation at last follow-up.
Results: Of the 91 patients analyzed, 46 (50.5%) required percutaneous interventions. The most frequent proce-
dures were pulmonary artery angioplasty and angioplasty of the Fontan conduit. Estimated survival at 10, 20
and 30 years of age was 96.2%, 94.7% and 89.4%, respectively. There were no signiﬁcant differences in survival
of patients undergoing percutaneous interventions or not. Overall survival and time to indication of percutaneous
interventionswere signiﬁcantly lower in the group of patientswith rightmorphology systemic ventricle. Patients
with fenestrated Fontan required interventions more frequently. At the end of follow-up, 66 patients (72.5%)
were asymptomatic, without signiﬁcant differences between patients who underwent or did not undergo percu-
taneous interventions.
Conclusions: Interventional catheterization procedures are often necessary to reach andmaintain the fragile Fontan
circulation, mainly in patients with right morphology systemic ventricles and fenestrated Fontan conduits.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Total cavopulmonary derivation (TCD) surgery consists, regardless
of the changes emerged since the ﬁrst description of the technique by
Fontan in 1971 [1], in the connection of the systemic venous ﬂow to
the pulmonary arteries passively, bypassing the ventricular impulse.
This is performed through the direct connection of the superior vena
cava (SVC) to the pulmonary branches in a ﬁrst staged surgery (Glenn
operation), and of the inferior vena cava (IVC) in a second staged proce-
dure (Fontan operation), achieving so a complete venous return deriva-
tion into the pulmonary circuit.
For such univentricular physiology, favorable anatomic and hemody-
namic parameters are needed. These are frequently achieved only withrior vena cava; NYHA, NewYork
superior vena cava; TCD, total
al Cardiology Unit, Pediatric
ospital, Paseo de la Castellana,
omingo).
land Ltd. This is an open access articlprevious percutaneous or surgical procedureswhennecessary. In general,
these determinants include a sufﬁcient but not excessive pulmonary ﬂow
in early stages, optimal ventricular function, absence of signiﬁcant steno-
sis or regurgitation of the systemic atrioventricular valve, sinus rhythm,
low pulmonary resistance and pulmonary arteries of adequate size [2].
In recent years, given the increased survival of patients with Fontan
circulation, percutaneous techniques have emerged for new indications
or to solve complications, which aim to keep this fragile physiology in op-
timal circumstances.We present in this paper the cumulativework expe-
rience in structural percutaneous procedures performed at our institution
over the past 18 years in patients with univentricular physiology.2. Materials and methods
2.1. Study population and analyzed variables
All patients who had a TCD completed at La Paz Children's University
Hospital inMadrid from1995 toOctober 2013, and at least one follow-up
visit, were included. No patients with cavopulomonary bypass pendinge under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ogy were included. The variables were collected retrospectively from
medical reports and paper or computerized clinical history of patients.
In addition to demographic data, information on the type of congenital
heart defect (CHD), the date of Glenn surgery and Fontan surgery, the
date of each interventional catheterization, and the type of procedure
performed were obtained. Moreover, information on the need of other
than Glenn or Fontan surgery during follow-up was collected. Three pe-
riods of time were considered for presentation of the results regarding
the performance of percutaneous interventions (PIs): prior to Glenn sur-
gery (pre-Glenn), between Glenn and Fontan surgery, and after Fontan
surgery (post-Fontan). The last date of follow-up of each patient, and
the date of death in patients who died, were recorded. Also, the overall
clinical status of each patient at follow-up, according to their functional
New York Heart Association (NYHA) class, and the presence of relevant
issues related to the failure of Fontan circulation, such as protein-losing
enteropathy, plastic bronchitis, desaturation (arterial oxygen saturation
below 90%) or inclusion on heart transplant list, were recorded. To assess
the clinical outcome andmortality of the patientswith follow-up in other
centers, a telephone contact was made in October 2013, by the end date
of the overall monitoring of the cohort.
All data were recorded and used in accordance with the applicable
data protection laws and ethical principles of the Declaration of
Helsinki.
2.2. Indication of percutaneous interventional procedures
Indications of the different types of PI were mainly proposed by the
clinical cardiologist responsible for each patient's follow-up in our
high-resolution (clinical evaluation + electrocardiogram + echocardi-
ography) outpatient clinics. Other times, it is the interventional cardiol-
ogist whoproposed a speciﬁc PI based on the hemodynamic or anatomic
ﬁndings in pre-Glenn and pre-Fontan diagnostic catheterizations that,
most of the times, all patients on the way to univentricular physiology
undergo. In any case, all PI proposedwere discussed andﬁnally indicated
during Children Heart Team meetings where clinicians, interventionalTable 1
Basal characteristics of the cohort of patients.
Total cohort
(n = 91)
Patients with percu
(n = 46)
Demographic characteristics
Age at last follow-up or death (years) 15.5 ± 5.4 14.6 ± 5.8
Age at Glenn surgery (years) 1.6 [0.9–3.1] 1.5 [0.8–3.0]
Age at Fontan surgery (years) 7.0 ± 2.8 6.8 ± 2.7
Males (%) 57 (62.6) 30 (65.2)
Cardiopathy
Hypoplasia/atresia of left ventricle/valves (%) 37 (40.7) 26 (56.5)
– Hypoplastic left ventricle⁎ 13 11
– Double outlet RV with ventricular disbalance 12 5
–Mitral atresia 5 4
– Shone syndrome 4 4
–Mitral-aortic atresia 2 2
– Criss-cross heart 1
Atresia or stenosis of right valves (%) 37 (40.7) 15 (32.6)
– Tricuspid atresia 20 6
– Pulmonary atresia with intact septum 6 2
– Hypoplastic RV⁎ 5 3
– L-TGA with pulmonary atresia 3 1
– Tricuspid and pulmonary atresia 2 2
– D-TGA with tricuspid stenosis 1 1
Left morphology single ventricle (%) 9 (9.9) 3 (6.5)
Right morphology single ventricle (%) 8 (8.8) 2 (4.3)
Systemic ventricle
Left morphology (%) 42 (46.2) 16 (34.8)
Right morphology (%) 49 (53.8) 30 (64.2)
Continuous variables are presented as mean ± standard deviation (normal distribution) or as m
comparisons between patients with and without percutaneous interventions. RV: right ventricle
⁎ Cases of ventricular hypoplasia without a primary valvular cause.cardiologists and surgeons responsible for the care of each patient
participated.
2.3. Cardiac catheterization
All catheterizations were performed under general anesthesia and
mechanical ventilation with endotracheal intubation. The route of ve-
nous access was femoral or jugular and arterial access was femoral.
2.4. Statistical analysis
Qualitative variables were expressed as percentages and the rela-
tionships between them were analyzed using the χ2 test or Fisher's
exact test. Quantitative variables were expressed as mean ± standard
deviation for normally-distributed variables, or asmedian [interquartile
range] for variables which were not normally distributed. To test the
hypothesis of normal distribution of quantitative variables, the
Kolmogorov–Smirnov test was used. Relationship between continuous
variables of normal distribution was analyzed according to the number
of existing categories, using the Student t test or ANOVA with post-
analysis according to the Bonferroni method; continuous variables not
normally distributed were analyzed using Mann–Whitney or Kruskal–
Wallis tests, depending on the number of categories. Signiﬁcant value
of p b 0.05 (two-tailed) was considered statistically signiﬁcant. For the
overall survival analysis and time to the indication of PI, the Kaplan–
Meier method was used. Comparisons were performed using the
log-rank test. The statistical analysis was performed using SPSS PASW
statistics 15.0 package (SPSS Inc., Chicago, Illinois, United States).
3. Results
From 1995 to October 2013, a total of 91 patients with CHD
underwent a TCD in two stages: ﬁrst the superior cavopulmonary
connection (Glenn surgery), and in a second time the inferior
cavopulmonary connection (Fontan). In 15 patients (16.5%) our team
opted for a fenestration of the Fontan conduit into the right atriumtaneous interventions Patients without percutaneous interventions
(n = 45)
p
16.4 ± 4.9 0.107
2.0 [1.3–3.2] 0.249
7.3 ± 3.0 0.409
27 (60.0) 0.607
11 (24.4) 0.014
2
7
1
1
22 (48.9) 0.250
14
4
2
2
6 (13.3) 0.317
6 (13.3) 0.157
26 (57.8) 0.028
19 (42.2)
edian [interquartile range] (non-normal distribution). Right column shows the p value for
; L-TGA: L-transposition of the great arteries; D-TGA: D-transposition of the great arteries.
Table 2
Percutaneous interventions performed.
Number (%) Age of patients (years) Time from last surgery (years)⁎
Pre-Glenn procedures 7 0.81 ± 0.97
Coarctation/recoarctation of aorta angioplasty 5 (71.4%) 1.01 ± 1.12
Angioplasty of both pulmonary arteries 1 (14.3%) 0.35
Angioplasty of right pulmonary veins 1 (14.3%) 0.33
Pre-Fontan procedures 30 4.34 ± 3.06 2.44 ± 2.54
Pulmonary artery/arteries angioplasty 19 (63.3%) 4.50 ± 2.76 2.65 ± 2.12
Angioplasty of the Glenn “conduit” 2 (6.7%) 1.64 and 8.90 0.13 and 1.00
Coarctation/recoarctation of aorta angioplasty 2 (6.7%) 2.38 and 7.39 1.21 and 6.22
Embolization of collateral vessels 2 (6.7%) 0.69 and 3.51 0.12 and 1.92
Angioplasty of the Glenn “conduit”+ both PAB 1 (3.3%) 0.51 0.08
Angioplasty of LPA + embolization of LSVC 1 (3.3%) 11.39 10.22
Angioplasty of left pulmonary veins 1 (3.3%) 0.65 0.08
Angioplasty of superior vena cava 1 (3.3%) 3.30 0.42
Angioplasty of the aortopulmonary anastomosis
(Damus–Kaye–Stansel surgery)
1 (3.3%) 4.30 1.42
Post-Fontan procedures 36 14.09 ± 4.90 7.38 ± 4.50
Angioplasty of the Fontan conduit 9 (25.0%) 18.32 ± 2.40 11.61 ± 2.21
Pulmonary artery/arteries angioplasty 8 (22.2%) 10.64 ± 4.30 4.65 ± 2.68
Embolization of collateral vessels 5 (13.9%) 13.89 ± 7.15 6.98 ± 6.52
Angioplasty of the Fontan conduit + PAB 2 (5.5%) 13.35 and 17.30 4.00 and 12.32
Fontan conduit fenestration closure 2 (5.5%) 6.44 and 17.78 2.42 and 11.17
Fontan conduit angioplasty + fenestration closure 2 (5.5%) 15.91 and 18.02 8.93 and 9.84
Enlargement of Fontan conduit fenestration 2 (5.5%) 7.29 and 14.26 1.98 and 9.92
Embolization of modiﬁed BT ﬁstula 2 (5.5%) 7.43 and 13.10 0.06 and 3.67
Angioplasty of PAB + collateral vessels embolization 1 (2.8%) 15.05 8.55
Glenn angioplasty + collateral vessel embolization 1 (2.8%) 11.94 5.33
Embolization of LSVC 1 (2.8%) 15.75 9.36
Occlusion of pulmonary main artery with device 1 (2.8%) 13.46 1.59
All procedures 73 9.43 ± 6.63 5.15 ± 4.46
Continuous variables are presented as mean ± standard deviation. PAB: main pulmonary artery branches; LPA: left pulmonary artery; LSVC: left superior vena cava; BT: Blalock–Taussig.
⁎ In pre-Fontan procedures, time fromGlenn surgery is shown; in post-Fontan procedures, time from Fontan surgery is shown; in all procedures, the age of the patient was considered
for pre-Glenn procedures.
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was performed, and in 2 patients a Kawashima procedure (derivation
of the hepatic veins to the pulmonary arterywhen absence of the hepat-
ic portion of the IVC is patent) was performed. 46 out of 91 patients
(50.5%) had at least one interventional cardiac catheterization per-
formed. Demographic characteristics, underlying CHD and the age at
Glenn and Fontan surgeries are shown in Table 1. Patients with right
morphology systemic ventricle needed PImore frequently than patients
with left morphology systemic ventricle (61.2% vs. 38.1%, p = 0.028).
The underlying CHD differed signiﬁcantly between patients undergoingFig. 1. Temporal distribution Fontan operations (left) and interventional catheterizations (righ
terizations performed pre-Glenn surgery, between Glenn and Fontan surgeries, and post-Fontaor not PI (p= 0.015), being particularly more frequent in patients with
hypoplasia/atresia of the left ventricle/valves (p = 0.014). There were
no signiﬁcant differences in the age at which Glenn or Fontan surgeries
were done between patients undergoing or not PI. In the 46 patients
needing PI, a total of 73 procedures were done. The median number of
interventional catheterizations per patient was 1 [1–2]. The description
of the procedures performed and the timing of them are shown in
Table 2. Angioplasty procedures described include both simple
(balloon) angioplasties and angioplasties with stent placement. The
yearly distribution of Fontan operations (time when the TCD ist) performed in the cohort of patients. For each year, the number of interventional cathe-
n surgery, is exposed. TCD: Total cavopulmonary derivation.
Fig. 2. Overall survival and survival after Fontan operation among patients undergoing or
not undergoing PI.
Table 3
Deceases.
Cardiopathy Percutaneous
interventions
performed
Age
(years)
Time from Fontan
surgery
(years)
Cause of death
1 Hypoplastic left
ventricle
Yes 7.71 2.30 Sudden death.
2 Shone syndrome Yes 7.80 0.77 Cardiogenic shock in the early post-operative period of heart transplant.
3 Single right ventricle Yes 12.72 0.10 Cardiogenic shock and sepsis in the early post-operative period of Fontan
surgery.
4 Mitral atresia Yes 9.69 4.61 Sudden death.
5 Single right ventricle No 18.04 10.78 Sudden death.
6 Single right ventricle No 17.24 11.21 Sudden death.
141E. Franco et al. / IJC Heart & Vasculature 8 (2015) 138–146completed) performed along the period of review and corresponding PI,
is represented in Fig. 1.
Before Glenn surgery, 6 patients underwent PI. A single procedure
was performed in 5 patients, whereas the remaining one needed two
consecutive aortic coarctation balloon angioplasties. Themost common
procedure along this period was the angioplasty of coarctation or
recoarctation of the aorta.
Between Glenn and Fontan surgeries, 21 patients underwent PI. In
13 patients a single procedure was performed, in 7 patients two proce-
dures were done, and in one patient three procedures were carried out:
aortic coarctation and recoartation balloon angioplasties, and a complex
procedurewhich included left pulmonary artery angioplasty and embo-
lization of left superior vena cava. Globally, the most common proce-
dure was pulmonary artery angioplasty.
Finally, after Fontan surgery, 30patients underwent PI. In 25patients
a single procedure was necessary, in 4 patients two procedures were
performed, and in one patient three procedures (angioplasty of pulmo-
nary arteries, and two consecutive angioplasties of the Fontan conduit)
were done. Along this period of time, the most common PI was the an-
gioplasty of the Fontan conduit and pulmonary artery branches. When
comparing both pulmonary artery branches and Fontan conduit angio-
plasties, pulmonary angioplasties were performed in younger patients
(p b 0.001) and sooner since Fontan surgery (p b 0.001). In patients in
whom a fenestrated Fontan had been done, PI was needed more fre-
quently than in patients with non-fenestrated Fontan (60% vs. 27.6%,
p = 0.015). 4 fenestration closure procedures were performed during
follow-up.
3.1. Overall survival of the cohort of patients
After a mean follow-up of 15.5 ± 5.4 years (median follow-up 16.8
[11.4 to 19.5] years), in the cohort of 91 patients there were 6 deaths
(totalmortality 6.6%), one of whichwas caused by complications during
the early post-operative period of Fontan surgery, and another in the
post-operative period of cardiac transplantation (performed shortly
after the Fontan operation). All deaths occurred in the group of patients
with right morphology systemic ventricle. There were 4 deaths in the
group of patients undergoing PI, and 2 in the group without interven-
tion (p = 0.320). No death was directly related to or occurred during
a catheterization, or was due to complications of it. Among the 15 pa-
tients who had undergone fenestrated Fontan surgery, no deaths were
observed. Causes of death and underlying CHD of deceased patients
are shown in Table 3. Estimated survival at 10, 20 and 30 years of age
was 96.2% (95% CI: 92.1%–100%), 94.7% (95% CI: 94.2%–99 8%) and
89.4% (95% CI: 80.8%–98.0%), respectively. There was no signiﬁcant dif-
ference between survival of patients undergoing or not PI (Fig. 2). Sur-
vival was signiﬁcantly lower in patients with right morphology
systemic ventricle than in thosewith leftmorphology systemic ventricle
(p=0.02) (Fig. 3). Estimated survival after TCD (Fontan operation)was
completed, at 10 and 20 years of follow-up, was 95.1% (95% CI: 90.4%–
99.8%) and 89.1% (95% CI: 79.9%–98.3%), respectively.3.2. Time to the indication of percutaneous intervention
Mean time to the ﬁrst PI was 16.1 years (95% CI 14.2 to 18.1 years).
This time was shorter in patients with right morphology systemic ven-
tricle (13.7 years, 95% CI: 11.1 to 16.3 years vs. 18.87 years, 95% CI: 16.2
to 21.5 years, p = 0.015) (Fig. 4). The estimated percentage of patients
free of PI at 1, 5 and 10 years of age was 93.1% (95% CI: 87.9%–98.4%),
82.8% (95% CI: 75.0%–90.6%) and 72.1% (95% CI: 62.7%–81.5%),
respectively.
Fig. 4. Time to ﬁrst percutaneous intervention in patients with right or left systemic
ventricle.
Fig. 3.Overall survival and survival after Fontan operation in patientswith right or left sys-
temic ventricle.
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also analyzed considering three periods of time: prior to Glenn surgery,
between Glenn and Fontan surgeries and after Fontan surgery, when
TCD was completed (Fig. 5). For the ﬁrst two periods of time, follow-
up was only considered until Glenn surgery and Fontan surgery,Fig. 5. Patients undergoing percutaneous interventions. Time to ﬁrst percutaneous inter-
vention along three different time periods: before Glenn surgery (pre-Glenn), between
Glenn and Fontan surgeries, and after Fontan surgery (post-Fontan).
Table 4
Surgeries other than Glenn and Fontan operations, excluding pre-Glenn palliative procedures, fenestration openings and heart transplants.
Diagnosis Surgical treatment Age
(years)
Time from Glenn
surgery⁎
Time from Fontan
surgery⁎
1 Thrombosis of the superior cavopulmonary derivation (Glenn). Thrombectomy. 3.44 58 days
2 Persistent LSVC draining into the coronary sinus.
Sinus node dysfunction.
LSVC ligation.
Epicardial pacemaker implant.
4.47 1.4 years
Pacemaker battery end-of-life. Pacemaker generator replacement. 8.15 5.0 years
Fontan Kawashima with desaturation.
Pacemaker battery end-of-life.
Inclusion of suprahepatic veins into Fontan circulation.
Pacemaker generator replacement.
11.57 19 days
Median sternotomy infection. Desbridement and aspiration drain insertion. 11.63 39 days
3 Thrombosis of the inferior vena cava. Thrombectomy. 12.97 10 days
4 Postsurgical pericardial effusion. Aspiration drain insertion. 7.45 29 days
5 Acute postsurgical mediastinitis. Closed vacuum-drainage system insertion. 6.63 42 days
6 Chronic retrosternal ﬁstula retroesternal crónica. Fistulectomy. 13.10 7.7 months
Retrosternal membrane infection. Resection of the infected retrosternal membrane. 13.31 10.3 months
Retrosternal ﬁstula relapse Fistulectomy. 17.59 5.1 years
7 Tricuspid patch dehiscence. Resuture of the tricuspid patch. 4.93 10 months
8 Diffuse thrombosis of the Fontan prosthetic conduit. Thrombectomy. 11.68 3.2 years
9 Fontan conduit severe stenosis. Extracardiac Fontan conduit replacement. 17.97 11.0 years
LSVC: left superior vena cava.
⁎ For surgeries performed between Glenn and Fontan surgeries, time from Glenn surgery is displayed. For surgeries performed after Fontan operation, time from Fontan surgery is
shown.
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follow-up than 2 years in the pre-Glenn period, or 4 years in the period
of time between Glenn and Fontan surgeries. Mean time to PI after the
completion of Fontan circulation was lower for patients with fenestrat-
ed Fontan than for non-fenestrated patients (8.88 years, 95% CI: 7.1 to
10.6 years vs. 12.32 years, 95% CI: 10.8 to 13.8 years, p = 0.013).
3.3. Need for surgery other than Glenn or Fontan
In addition to superior and inferior cavopulmonary connections, and
excluding early pre-Glenn palliative procedures, that are often neces-
sary in these patients (such as systemic-to-pulmonary shunts), 4 pa-
tients (4.4%) required a surgical fenestration opening, and 9 patients
(10%) required other operations (one surgery for each patient, except
for 2 patients requiring 3 and 4 surgeries, respectively), mainly to
treat thrombotic problems or complications related to the Glenn or
Fontan operations (Table 4). In addition, 2 patients received a heart
transplant but one died in the immediate postoperative period.
3.4. Clinical outcomes
At the endof clinical follow-up, 66 patients (72.5%)were asymptom-
atic, 19 patients (20.9%) had symptoms and 6 patients had died. Among
symptomatic patients, 9 of them (9.8% of the total cohort) had NYHA
functional class ≥2. Clinical outcomes are listed in Table 5. All 3 patients
on awaiting list for heart transplantation have NYHA functional class III,
and one of them also suffer from protein-losing enteropathy. The sur-
viving transplanted patient had NYHA functional class IV and protein-
losing enteropathy. Among patients with follow-up in other centers, 6Table 5
Clinical outcomes at last follow-up. Patients with or without percutaneous interventions.
Clinical situation Total cohort
(n = 91)
Patients with percutaneo
(n = 46)
Asymptomatic (%) 66 (72.5) 31 (67.4)
Symptomatic/complications (%) 19 (20.9) 11 (23.9)
– NYHA functional class ≥ II (%) 9 4
– Cyanosis 10 6
– Protein-losing enteropathy 5 3
– Plastic bronchitis 4 2
– Inclusion on heart transplant list 3 3
– Heart transplantation (alive) 1
Deceased (%) 6 (6.6) 4 (8.7)
NYHA: New York Heart Association.were unable to contact, so only time until their last outpatient visit re-
ported was considered (Table 6).
At the end of follow-up, there were no signiﬁcant differences in the
clinical status of patients according towhether they underwent PI or not
(p=0.550 for the presence of symptoms or complications). Therewere
no signiﬁcant differences between patients with fenestrated or non-
fenestrated Fontan (p= 0.744 for the presence of symptoms or compli-
cations). Among the 10 patients with cyanosis, 3 patients had a fenes-
trated Fontan and another 3 were included in those 4 who required
surgical fenestration opening. Table 7 shows the clinical status at
follow-up of patients with right and left morphology ventricles. There
were no statistically signiﬁcant differences in the proportion of symp-
tomatic patients (excluding deaths), but in the group of patients with
right morphology ventricle we found 8 out of 10 cases of cyanosis, and
all cases of plastic bronchitis.
4. Discussion
This paper summarizes the review of a cohort of patients with or in
the way to univentricular circulation with structural percutaneous
procedures. Fontan circulation is based on a fragile physiology, where
discrete anatomical variations of size or pressure gradients imply large
variations in cardiac output, arterial oxygen saturation and functional
class.[3] Improvement of surgical techniques and the increasingly earli-
er age at which the TCD is completed have enabled the Fontan circula-
tion as a real alternative for a growing number of complex congenital
or acquired heart diseases in our environment. In addition, the
extracardiac TCD or modiﬁed Fontan, which has replaced the classic
atriopulmonary shunt, has signiﬁcantly reduced complications such asus interventions Patients without percutaneous interventions
(n = 45)
p
35 (77.7) 0.550
8 (17.8)
5
4
2
2
1
2 (4.4) 0.320
Table 6
Lost to follow-up.
Last follow-up
date
Age
(years)
Time from Fontan
surgery
(years)
1 June 2001 14.35 5.02
2 November 2001 7.80 0.77
3 June 2002 6.72 0.38
4 September
2002
8.26 1.10
5 February 2006 9.84 0.07
6 October 2006 15.51 12.51
144 E. Franco et al. / IJC Heart & Vasculature 8 (2015) 138–146arrhythmias andmortality in themost recent series.[4] The sheer size of
anatomic structures in childrenwith CHD and their longer survival have
increasingly made more necessary different PI techniques that aim to
keep Fontan circulation in optimum condition. In past decades, the fen-
estration of the inferior cavopulmonar derivation (Fontan conduit) was
considered beneﬁcial in the immediate postoperative management of
these patients because it ensured a greater systemic output and a
lower incidence of postoperative pleural effusions, at the expense of a
permissive degree of desaturation. In our cohort, only 16.5% of patients
had this fenestration performed, probably because the patients in our
study cohort represent a more recent cohort, in which the candidates
have been better selected and the vast majority of them had one or
more diagnostic catheterizations at which we demonstrated favorable
hemodynamic parameters for univentricular circulation to be possible.
This series includes only patients with CHD led to univentricular
physiology. Although new technical possibilities such as the pulmonary
valvular perforation with radiofrequency, or surgical, as the double
switch, allow to achieve a biventricular circulation in patients who
would have undergone univentricular palliantion decades ago, there are
still cases of extreme hypoplasia of one of the ventricles where this is
not possible. Thus, our study included 6 cases of pulmonary atresia with
intact ventricular septum, in which the Z score of right ventricular
dimensions was below −4 in all cases (all required a neonatal
systemic-to-pulmonary ﬁstula), or 3 cases of L-transposition of the
great arteries with pulmonary stenosis or atresia where the
subpulmonary left ventricle was extremely hypoplastic and biventricular
correction was not contemplated.
From a technical point of view, we can consider two groups of pa-
tients who may beneﬁt from PI in Fontan circulation. The ﬁrst includes
patientswith symptoms related to low cardiac output state and high ve-
nous pressures. The second includes those patients with progressive
desaturation, due either to residual right-to-left shunts (fenestration,
LSVC…), or the emergence of new shunts as veno-venous collaterals
(between systemic vein and pulmonary vein) or pulmonary arteriove-
nous ﬁstulae. The ﬁrst group would beneﬁt from percutaneous
techniques such as fenestration opening [5], angioplasty of stenotic
pathways such as Fontan conduit, pulmonary arteries, aortic coarctationTable 7
Clinical outcomes at last follow-up. Patients with right or left morphology systemic ventricle.
Clinical situation Right morphology systemic ventri
(n = 49)
Asymptomatic (%) 31 (63.3)
Symptomatic/complications (%) 12 (24.5)
– NYHA functional class ≥ II (%) 4
– Cyanosis 8
– Protein-losing enteropathy 2
– Plastic bronchitis 4
– Inclusion on heart transplant list 2
– Heart transplantation (alive)
Deceased (%) 6 (14.3)
NYHA: New York Heart Association.[6] or the anastomosis between the SVC and corresponding pulmonary
artery (Glenn connection). In the second one, however, we should think
of techniques such as fenestration closure (Fig. 6), veno-venous collat-
eral embolization, embolization of the persistent SVC or symmetric con-
duction of suprahepatic drainage ﬂow into both lungs to prevent the
development or to promote involution of arteriovenous ﬁstulae [7].
Approximately, one half of the patients required at least one cathe-
terizationwith structural PI, beingmore common in thosewith system-
ic right ventricle and fenestrated Fontan, and without signiﬁcant effects
in terms of mortality. This may be because patients with hypoplasia of
left cavities or valves require more complex operations (aortic advance,
Norwood with systemic-to-pulmonary shunt or Norwood–Sano,
Damus–Kaye–Stansel, arterial switch [8]…) and at younger ages than
patients with leftmorphology systemic ventricle. Another added reason
has to do with the appearance of symptoms or failure of the Fontan
circulation much earlier in the group of patients with a single right
ventricle [9].
It is predictable that the types of PI more frequently attempted were
different in each phase of the cavopulmonary derivation, as hemody-
namics in each one is different too. BeforeGlenn surgery, one should en-
sure sufﬁcient but not excessive pulmonary ﬂow, in order to avoid
cardiac failure symptoms and pulmonary vascular overﬂow damage,
and also resolve the presence of stenosis at any point of the aortic
arch. BetweenGlenn surgery and the completion of TCD, arterial oxygen
desaturation and the aim of reaching a sufﬁcient size of the pulmonary
arteries are themost common reasonswhy PI is required, so pulmonary
artery angioplasty and right-to-left shunt embolization are the most
common procedures. More controversial is the beneﬁt of systematic
embolization of systemic-to-pulmonary ﬁstulae that usually appear be-
tween Glenn and Fontan surgeries [10]. Upon TCD, symptoms of low
cardiac output and failed Fontan (protein losing enteropathy [11] plastic
bronchitis [12]…) have sometimes an obstructive underlying mecha-
nism, and therefore, the angioplasty of the Fontan conduit is the most
frequently performed procedure (Fig. 7). In the description of the re-
sults, we have included under the term “angioplasty” both simple
(balloon) angioplasties and angioplasties with stent placement. For rea-
sons of size, angioplasties performed in the pre-Glenn stage are simple
angioplasties. Subsequently, stent implantation is mandatory if avail-
able for the weight of the patient and if the vascular access size is big
enough. This last attitude, however, varies depending on the operator
and the technical difﬁculty. Throughout the years, the smaller size of
the introducers and balloons required for stent implantation, and the
advent of new low-proﬁle premounted stents with the possibility of
postdilation to adapt their diameter to somatic growth, have made the
use of stents increasingly more common in angioplasties of the Fontan
conduit, pulmonary arteries and aortic arch. Consequently, the number
of interventional procedures with stent implantation in the last years of
the series is greater than at the beginning. We consider pulmonary ar-
tery angioplasty indicated when transarterial gradient is above
1 mm Hg or when pulmonary angiograms show stenosis over 20% ofcle Left morphology systemic ventricle
(n = 42)
p
35 (83.3) 0.385
7 (16.7)
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2
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Fig. 6. Fenestration closure device in a patientwho had undergone previous angioplasty in
the left pulmonary artery with stent (solid arrow). A: Fontan conduit in initial angiogra-
phy,where contrast ﬂow through the fenestration (asterisk) to right atriumwas observed.
B: An Atrial Septal Occluder device (Amplatzer™) (dotted arrow) was implanted for fen-
estration closure, showing no residual shunt in control angiography.
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tle hemodynamic variations can cause major clinical deterioration and
cardiac output decrease in these patients.
The age at which the pulmonary artery angioplasties were per-
formed was signiﬁcantly lower than the age at which the Fontan con-
duit angioplasties were done, probably because the growth of the
pulmonary arteries between Glenn and Fontan surgeries is relatively
slower than that of the IVC, since the effective pulmonary blood ﬂow
(Qp) in this phase is less than systemic ﬂow (Qs)with a relationship be-
tween both (Qp/Qs) of approximately 0.6. Sometimes, the distortion
generated because of the traction of the superior cavopulmonary anas-
tomosis on the right pulmonary branch cannot be completely relieved
at the moment of TCD, thus needing earlier percutaneous dilation.
Overall estimated survival up to 30 years of age in our series is slight-
ly higher than that obtained in other less recent series, with a signiﬁ-
cantly higher mortality in patients with systemic right ventricle,
which is consistent with those series [9,13]. This may be related to a
worse systolic and diastolic function of the right morphology systemicFig. 7. Fontan conduit angioplasty and fenestration closure. A: Fontan conduit stenosis (solid ar
previous embolization of the left superior vena cava had been done with a Duct Occluder devi
stents were initially implanted in the Fontan conduit (solid arrow), with a mild luminal widenin
ﬂow through the fenestration (dotted arrow). C: Finally, a covered in-stent stent was implanteventricles when compared with the left morphology ones [9,14], or
when compared with right ventricles in biventricular physiology
(subpulmonary right ventricle) [15]. Excluding deaths, absence of sig-
niﬁcant differences in the clinical status of patients at follow-up accord-
ing to whether they underwent any PI suggests, somehow, that these
procedures are effective to maintain adequate functional class and
treat clinical complications that would be corrected surgically other-
wise. We interpret the absence of deaths or serious complications relat-
ed to the procedures of PI as an indicator of safety and feasibility.
According to reports from other recent cohort [16], the Fontan con-
duit fenestration did not seem to inﬂuence the clinical status at follow-
up in our patients and is a factor associated with increased need for IP
itself. Although there are no devices speciﬁcally designed for this pur-
pose, the closure of the fenestration can be performed using different
closures devices for ventricular septal defects, atrial septal defects, pat-
ent ductus arteriosus or patent foramen ovale [17]. In our cohort, fenes-
tration closure was performed in 4 out of 15 (26.7%) patients with
fenestrated Fontan, but only 4 among the non-fenestrated patients
(5.2%) needed a fenestration to be opened (surgical). At our institution,
fenestration closures are indicated in patients with arterial oxygen sat-
uration b90% and normal pressures in the Glenn–Fontan system. Before
implanting the closure device, we perform an occlusion test inﬂating a
balloon in order to exclude pressure increase. The intervention is con-
sidered successfulwhen no contrast pass is patent through the fenestra-
tion during control angiograms, arterial oxygen saturation increases to
N90% with FiO2 ≤ 0.3, and there are no pressure raise in the Glenn–
Fontan system.
We should not forget that all this cumulative experience in PI
evolves in parallel with the development of new materials such as
bioabsorbable stents [18], and new technology in the catheterization
laboratories, as the possibility of acquiring 3D rotational images [19].
In Fontan circulation, new approaches and techniques for electrophysi-
ological studies and ablation of tachycardia when indicated should be
considered, once the endovenous access is lost when TCD is completed
[20]. Such advances make it possible to perform these relatively expen-
sive and complex procedures, requiring a high level of technology and
expertise. Although there are no randomized studies that allow us to
comparatively analyze survival, it seems sensible that thanks to these
techniques the number of reoperations could be reduced, thereby
avoiding the complications inherent in this group of patients. In this
sense, it would be useful to create nationwide or multinationalrow) and permeable fenestration (dotted arrow) were observed in baseline angiography;
ce (Amplatzer™) and a Vascular Plug II device (Amplatzer™) (asterisk). B: Two open-cell
g (but sufﬁcient to eliminate the 4mmHg gradient recorded), and persistence of contrast
d for fenestration sealing (key), without observing residual shunt in control angiogram.
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experience in these procedures. Only in this way it would be possible
to compare the effectiveness of the different available techniques to
achieve each therapeutic goal, which is not possible with just single-
center records given the wide variety of procedures performed and
the small number of patients undergoing each of them. Collaborative
work with grown up CHD units seems of vital importance in these reg-
istries, since only then could we know the ﬁnal outcome of these pa-
tients and the long-term results of the procedures performed. These
grown up CHD units will face the challenge of managing complications
and deterioration of univentricular physiology in the near future.
5. Limitations
The main limitation of this study is the retrospective nature of the
data analysis, although the collection of the data was performed
prospectively. Moreover, it has not speciﬁcally examined the efﬁcacy
of each performed interventional procedure. As a proxy for effective-
ness, no patient required surgery as a result of failure or complications
of a percutaneous procedure. In terms of security, there were no
procedure-related deaths. Another limitation is that this series only in-
cluded patients with complete TCD, so the results cannot be extrapolat-
ed to patients who have only had a partial cavopulmonary derivation
done or are still awaiting completion of Fontan circulation.
6. Conclusions
Different types of interventional catheterization procedures are nec-
essary to maintain the fragile univentricular physiology. These
techniques can solve many clinical problems and may avoid some
operations. Patients with right systemic ventricle are more likely to
require interventional procedures, and have a worse prognosis than
patients with a left systemic ventricle. Fontan fenestration did not
seem to inﬂuence the ﬁnal clinical status at follow-up in our cohort of
patients, but is associated with a higher likelihood of needing PI.
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